How GLP-1 weight-loss drugs are reshaping the healthcare industry
A new report says GLP-1 weight-loss drugs drove a 34.1% drop in bariatric surgery volumes as semaglutide reshapes how hospitals generate revenue.
Full story
Read the full story at Fox Business ↗
Continue reading this story on Fox Business, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
